Prestige BioPharma Balance Sheet

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Cash & Equivalents	143,653	219,433	125,022	268,651	458,975	45,976	Upgrade
Short-Term Investments	69,621	9,381	176,390	25,584	-	2,423	Upgrade
Trading Asset Securities	-	-	-	9,035	377.68	-	Upgrade
Cash & Short-Term Investments	213,273	228,815	301,412	303,270	459,353	48,399	Upgrade
Cash Growth	-15.56%	-24.09%	-0.61%	-33.98%	849.10%	391.62%	Upgrade
Accounts Receivable	4,290	391.6	132.72	-	-	-	Upgrade
Receivables	4,290	391.6	132.72	-	-	-	Upgrade
Inventory	22,629	18,103	7,146	2,157	-	-	Upgrade
Prepaid Expenses	-	2,733	2,731	-	-	1,412	Upgrade
Other Current Assets	2,577	309.41	53.44	6,139	584.08	-	Upgrade
Total Current Assets	242,770	250,352	311,476	311,566	459,937	49,811	Upgrade
Property, Plant & Equipment	343,967	327,062	310,438	38,342	6,437	4,519	Upgrade
Long-Term Investments	-	-	-	74,710	24,159	9,049	Upgrade
Goodwill	11,385	10,785	10,192	-	-	-	Upgrade
Other Intangible Assets	33,589	31,327	29,877	4,288	450.33	386.92	Upgrade
Long-Term Deferred Charges	161,574	91,643	78,843	61,024	108,573	94,624	Upgrade
Other Long-Term Assets	675.99	551.5	775.14	9,883	4,611	1,709	Upgrade
Total Assets	793,961	711,720	741,600	499,813	604,166	160,098	Upgrade
Accounts Payable	4,916	2,282	462.15	2,624	-	-	Upgrade
Accrued Expenses	-	5,975	6,150	4,923	3,552	1,099	Upgrade
Short-Term Debt	55,727	15,439	31,188	-	2,873	-	Upgrade
Current Portion of Long-Term Debt	55,360	47,845	31,176	-	-	-	Upgrade
Current Portion of Leases	1,255	950.81	1,682	1,593	1,326	443.84	Upgrade
Current Unearned Revenue	-	-	-	-	565	231.5	Upgrade
Other Current Liabilities	59,195	73,366	64,231	32,654	5,730	6,702	Upgrade
Total Current Liabilities	176,452	145,857	134,888	41,794	14,046	8,477	Upgrade
Long-Term Debt	35,320	40,247	50,190	-	-	61.26	Upgrade
Long-Term Leases	858.84	624.04	1,326	2,656	3,571	2,373	Upgrade
Long-Term Unearned Revenue	-	-	-	25,427	11,588	11,387	Upgrade
Long-Term Deferred Tax Liabilities	8,154	7,755	7,368	-	-	-	Upgrade
Other Long-Term Liabilities	32,098	1,734	1,593	0	-	-	Upgrade
Total Liabilities	252,882	196,219	195,365	69,877	29,206	22,299	Upgrade
Common Stock	770,979	730,340	690,175	679,713	594,072	152,779	Upgrade
Additional Paid-In Capital	-34,346	7,865	7,286	7,175	-	-	Upgrade
Retained Earnings	-278,695	-294,797	-246,151	-259,601	-27,954	-21,891	Upgrade
Comprehensive Income & Other	-15,127	-4,321	-798.76	2,649	8,843	6,911	Upgrade
Total Common Equity	442,810	439,087	450,511	429,936	574,961	137,799	Upgrade
Minority Interest	98,268	76,414	95,724	-	-	-	Upgrade
Shareholders' Equity	541,078	515,502	546,235	429,936	574,961	137,799	Upgrade
Total Liabilities & Equity	793,961	711,720	741,600	499,813	604,166	160,098	Upgrade
Total Debt	148,520	105,106	115,561	4,249	7,771	2,878	Upgrade
Net Cash (Debt)	64,753	123,708	185,851	299,020	451,582	45,521	Upgrade
Net Cash Growth	-53.51%	-33.44%	-37.85%	-33.78%	892.04%	-	Upgrade
Net Cash Per Share	1075.33	2058.50	3092.56	4975.70	8751.18	1067.23	Upgrade
Filing Date Shares Outstanding	300.48	300.48	300.48	300.48	300.48	42.65	Upgrade
Total Common Shares Outstanding	300.48	300.48	300.48	300.48	300.48	42.65	Upgrade
Working Capital	66,317	104,494	176,588	269,771	445,890	41,335	Upgrade
Book Value Per Share	1473.67	1461.28	1499.30	1430.83	1913.47	3230.70	Upgrade
Tangible Book Value	397,836	396,976	410,442	425,647	574,510	137,413	Upgrade
Tangible Book Value Per Share	1324.00	1321.13	1365.95	1416.55	1911.97	3221.62	Upgrade
Land	27,788	27,704	26,567	12,055	-	-	Upgrade
Buildings	137,403	77,472	76,415	-	-	-	Upgrade
Machinery	74,606	72,427	51,848	10,175	3,455	2,809	Upgrade
Construction In Progress	112,255	152,876	169,147	15,415	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.